newsfilter
← Latest News
PR Newswire·

Origin Agritech Announces Financial Results for the First Half of Fiscal Year 2026

SEED
  • Origin Agritech Ltd. reported a net loss of RMB 14.4 million (US$2.1 million) for the six months ended March 31, 2026, a 44% narrowing from RMB 25.6 million in the prior year period.
  • Operating expenses decreased by 43.9% to RMB 18.4 million, driven by a 69.8% reduction in general and administrative expenses to RMB 7.6 million.
  • Revenue fell 31.9% to RMB 49.2 million due to a strategic shift toward selling new corn seed products while reducing external tolling services.
  • The company launched the "Aoyun 2026" New Variety Promotion Program in March 2026 to accelerate market adoption of high-performing corn hybrids including Jingke 317, Jinqiao 8, Xundan 203, & Aoyu 728.
  • In November 2025, Origin secured a patent license for the Cas-SF01 gene-editing nuclease from Shunfeng BioTech to advance stacked-trait hybrid commercialization.
  • The company re-entered the Northeast China corn market in October 2025 & expanded its national organization from 63 to 106 professionals during fiscal year 2025.
  • Beijing Origin Seed Limited received regulatory approval in October 2025 to include GMO crop seed production in its business scope & obtained a formal crop seed production license from Beijing authorities.
  • Origin now holds two crop seed production & operation licenses in China, expanding its regional footprint alongside its Hainan subsidiary license.
  • Dr. Jian Zhang was appointed as an independent director in March 2026, & Dr. Z. James Chen returned as Chief Financial Officer to strengthen technical & capital markets expertise.
  • R&D expenses increased by 11.1% to RMB 5.7 million as the company continued investing in its proprietary breeding & biotechnology pipelines.
  • The company's BBL2-2 transgenic maize program holds a GMO safety certificate & incorporates dual insect-resistance & glyphosate-tolerance traits.
  • Origin's national R&D platform houses over 200,000 corn germplasm resources & utilizes AI-assisted breeding to shorten trait validation timelines.
  • As of March 31, 2026, the company held cash & cash equivalents of RMB 13.4 million with total assets of RMB 92.6 million.
  • Total current liabilities stood at RMB 155.6 million, with short-term borrowings totaling RMB 9.5 million.
  • The company will host a conference call on May 22, 2026, to discuss financial results & business updates.